Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Janssen-Cilag Guselkumab receives UK nod for Crohn's disease, ulcerative colitis

Ruchika Sharma20 May 2025 2:45 PM IST

Janssen-Cilag Limited has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for guselkumab (Tremfya) to treat...

CDSCO Panel Approves GSKs Proposal to Double Indian Patient Pool in Dostarlimab Trial

GSK Blenrep combos win approval in Japan for multiple myeloma

Ruchika Sharma20 May 2025 1:45 PM IST

GSK plc has received approval for Blenrep combinations from Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of adults with...

AstraZeneca Datroway gets USFDA accelerated nod for previously treated advanced EGFR-mutated non-small cell lung cancer

AstraZeneca successfully completes acquisition of EsoBiotec

Ruchika Sharma20 May 2025 12:27 PM IST

AstraZeneca has successfully completed the acquisition of EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated...

Boehringer Ingelheim, LEO Pharma collaborate

Pfizer strikes cancer drug deal with China's 3SBio

Ruchika Sharma20 May 2025 11:30 AM IST

3SBio plans to initiate the first Phase 3 study in China in 2025.

JnJ seeks USFDA approval for Icotrokinra for plaque psoriasis

USFDA clears first blood test used in diagnosing Alzheimer's Disease

Ruchika Sharma19 May 2025 5:03 PM IST

The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing...

Marksans Pharma arm Relonchem gets marketing authorization for Sennosides Tablets in UK

Ruchika Sharma19 May 2025 4:00 PM IST

Mumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary Relonchem Limited has received Marketing Authorization for the...

Cipla India Rx promotes Amit Patel to Head - Consumer Marketing Excellence

New Role Alert: Amit Patel named Head - Consumer Marketing Excellence, Cipla India Rx

Ruchika Sharma19 May 2025 3:05 PM IST

Amit Patel has been elevated to Head - Consumer Marketing Excellence, Cipla India Rx.Patel announced the development through a LinkedIn post, stating,...

Authorities Investigate Death of Young Doctor in Hospital Restroom

Medical store horror: Sulphas given for toothache kills woman

Ruchika Sharma19 May 2025 2:30 PM IST

Jhabua: A visit to a medical store for toothache relief turned tragic for a 32-year-old woman in Madhya Pradesh's Jhabua district after she was...

Fresenius Told To Submit Approval Basis, Phase III Data for Calcium Chloride Dihydrate Infusion Proposal

Indian pharma sector grows at 7.8 percent in April

Ruchika Sharma19 May 2025 1:00 PM IST

India’s Pharma Sector has registered a 7.8 percent year-on-year growth in April 2025, driven by strong demand and new products, as per the...

Cipla EU incorporates new wholly owned subsidiary in Germany

Cipla arm Mahape facility gets VAI status from USFDA

Ruchika Sharma19 May 2025 11:00 AM IST

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has classified the current Good Manufacturing Practices...

Simplified export norms expected to be introduced in next few weeks: Rajeev Raghuvanshi

Pharma, Electronics, Engineering, Agri account for over half of India exports in FY25: Govt Data

Ruchika Sharma18 May 2025 5:00 PM IST

Pharmaceuticals, agriculture, electronics, and engineering goods collectively contributed more than 50 percent of the country's merchandise exports in...

Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer

Ruchika Sharma18 May 2025 2:30 PM IST

Basel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok